Scientists at La Jolla Institute for Immunology (LJI) have found that people with Parkinson's disease have a clear "genetic signature" of the disease in their memory T cells. The scientists hope that targeting these genes may open the door to new Parkinson's treatments and diagnostics.
New BioAge Drug Prevents Death From COVID-19 in Old Mice by Reversing Immune Aging
New Therapies Could Stop T Cells From Attacking Brain Cells in Parkinson’s Disease
